血管内超声与血管造影引导下肢外周动脉疾病血运重建的系统综述与荟萃分析
该系统综述与荟萃分析比较了血管内超声(IVUS)与血管造影引导下肢外周动脉疾病(PAD)腔内血运重建的效果。纳入2项随机试验(n=387)和19项观察性研究(n=1,164,329)。随机数据显示IVUS可能降低再狭窄(RR 0.59,95%CI 0.42-0.83,中等确定性),但再干预、死亡率和大截肢的影响不确定;观察性数据显示IVUS可能降低再狭窄、再干预、大截肢和死亡率,但证据确定性低。
要点
- 随机试验显示IVUS引导可能降低再狭窄风险(RR 0.59,中等确定性)。
- 观察性研究提示IVUS可能降低再干预、大截肢和死亡率,但证据确定性低。
- 仍需更大规模随机试验明确IVUS引导的获益。
核心结论
- 基于有限随机证据,IVUS引导可能降低再狭窄。
- 观察性研究提示IVUS在多个结局上可能有潜在获益,但证据确定性低。
- 需要更大规模随机试验来明确IVUS引导的潜在获益。
研究设计与样本
- 系统综述与 study-level 荟萃分析,检索Medline、Embase和CENTRAL从建库至2025年11月22日。
- 纳入2项随机对照试验(n=387)和19项观察性研究(n=1,164,329)。
- 随机试验与观察性研究分别分析,主要分析采用随机效应模型,使用GRADE评估证据确定性。
主要发现
- 随机数据:IVUS引导可能降低再狭窄(RR 0.59;95%CI 0.42-0.83;中等确定性)。
- 随机数据:IVUS可能不降低再干预(RR 0.68;95%CI 0.44-1.08;低确定性)或死亡率(RR 1.13;95%CI 0.37-3.42;低确定性),对大截肢影响非常不确定(RR 0.97;95%CI 0.14-6.73;极低确定性)。
- 观察性数据:IVUS可能降低再狭窄(RR 0.70;95%CI 0.54-0.90;低确定性)、再干预(RR 0.66;95%CI 0.48-0.90;低确定性)、大截肢(RR 0.83;95%CI 0.72-0.96;低确定性)和死亡率(RR 0.88;95%CI 0.84-0.93;低确定性)。
临床怎么用
- IVUS引导可能作为下肢PAD腔内血运重建的辅助手段以减少再狭窄,但需结合临床情况和证据确定性个体化决策。
- 观察性研究提示的获益需谨慎解读,不能替代随机试验证据。
局限性
- 随机证据有限(仅2项试验,n=387)。
- 观察性研究证据确定性低,可能存在混杂偏倚。
- 对大截肢和死亡率等硬终点的影响不确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aimed to conduct a systematic review and study-level meta-analysis of randomized controlled trials and observational studies comparing intravascular ultrasound (IVUS) guidance with angiography guidance for peripheral artery disease (PAD) endovascular revascularization, as current evidence is lacking. METHODS: We searched Medline, Embase, and CENTRAL from inception until November 22, 2025. Trials and observational studies were analyzed separately. We used random-effects as our primary analysis and assessed the certainty of evidence using Grading of Recommendations Assessment, Development and Evaluation. Key outcomes included restenosis, reintervention, major amputation, and mortality. RESULTS: We included two randomized trials (n = 387), and 19 observational studies (n = 1,164,329). According to randomized data, IVUS-guidance likely reduces restenosis compared with angiography-guidance [risk ratio (RR), 0.59; 95% confidence interval (CI), 0.42-0.83; moderate certainty]. However, IVUS may not reduce reintervention (RR, 0.68; 95% CI, 0.44-1.08; low certainty), or mortality (RR, 1.13; 95% CI, 0.37-3.42; low certainty), whereas its effect on major amputation is very uncertain (RR, 0.97; 95% CI, 0.14-6.73; very low certainty). However, based on observational data, IVUS may reduce restenosis (RR, 0.70; 95% CI, 0.54-0.90; low certainty), reintervention (RR, 0.66; 95% CI, 0.48-0.90; low certainty), major amputation (RR, 0.83; 95% CI, 0.72-0.96; low certainty), and mortality (RR, 0.88; 95% CI, 0.84-0.93; low certainty). CONCLUSIONS: IVUS guidance likely reduces restenosis based on limited randomized evidence. Observational studies suggest potential benefits across several outcomes, although the certainty of evidence is low. Larger randomized trials are required to clarify the potential benefits of IVUS guidance.
引用
- d'Entremont MA, McClure GR, Kowalik K, et al. Intravascular ultrasound versus angiography for lower-extremity peripheral artery disease endovascular revascularization: A systematic review and meta-analysis. J Vasc Surg. 2026. PMID: 42546858. doi:10.1016/j.jvs.2026.06.180
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。